Cadre (CDRE) Competitors $29.17 -0.15 (-0.51%) As of 04/30/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDRE vs. NARI, INSP, BLCO, SLNO, IRTC, TMDX, PRCT, NVST, LMAT, and LIVNShould you be buying Cadre stock or one of its competitors? The main competitors of Cadre include Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. Cadre vs. Inari Medical Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular LivaNova Inari Medical (NASDAQ:NARI) and Cadre (NYSE:CDRE) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, community ranking, valuation, earnings, dividends, analyst recommendations and risk. Which has more risk and volatility, NARI or CDRE? Inari Medical has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Does the MarketBeat Community favor NARI or CDRE? Inari Medical received 50 more outperform votes than Cadre when rated by MarketBeat users. Likewise, 57.89% of users gave Inari Medical an outperform vote while only 55.17% of users gave Cadre an outperform vote. CompanyUnderperformOutperformInari MedicalOutperform Votes6657.89% Underperform Votes4842.11% CadreOutperform Votes1655.17% Underperform Votes1344.83% Do analysts rate NARI or CDRE? Inari Medical presently has a consensus target price of $68.00, indicating a potential downside of 14.97%. Cadre has a consensus target price of $37.00, indicating a potential upside of 26.84%. Given Cadre's stronger consensus rating and higher possible upside, analysts clearly believe Cadre is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inari Medical 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14Cadre 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, NARI or CDRE? Cadre has higher revenue and earnings than Inari Medical. Inari Medical is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInari Medical$493.63M9.48-$1.64M-$1.35-59.24Cadre$567.56M2.09$38.64M$0.9032.41 Is NARI or CDRE more profitable? Cadre has a net margin of 6.34% compared to Inari Medical's net margin of -13.68%. Cadre's return on equity of 12.88% beat Inari Medical's return on equity.Company Net Margins Return on Equity Return on Assets Inari Medical-13.68% -10.09% -6.60% Cadre 6.34%12.88%6.06% Do insiders and institutionals have more ownership in NARI or CDRE? 91.0% of Inari Medical shares are held by institutional investors. Comparatively, 44.0% of Cadre shares are held by institutional investors. 10.6% of Inari Medical shares are held by insiders. Comparatively, 37.0% of Cadre shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media prefer NARI or CDRE? In the previous week, Cadre had 11 more articles in the media than Inari Medical. MarketBeat recorded 11 mentions for Cadre and 0 mentions for Inari Medical. Cadre's average media sentiment score of 0.66 beat Inari Medical's score of 0.00 indicating that Cadre is being referred to more favorably in the news media. Company Overall Sentiment Inari Medical Neutral Cadre Positive SummaryCadre beats Inari Medical on 13 of the 18 factors compared between the two stocks. Get Cadre News Delivered to You Automatically Sign up to receive the latest news and ratings for CDRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDRE vs. The Competition Export to ExcelMetricCadreSurgical appliances & supplies IndustryIndustrials SectorNYSE ExchangeMarket Cap$1.19B$9.15B$7.14B$18.97BDividend Yield1.30%1.64%3.56%4.03%P/E Ratio35.1419.2720.8232.71Price / Sales2.0971.1380.9427.84Price / Cash22.8919.6726.9417.53Price / Book5.564.953.744.47Net Income$38.64M$284.66M$807.45M$1.02B7 Day Performance-0.90%2.99%3.18%2.26%1 Month Performance0.19%-0.17%1.11%-2.86%1 Year Performance-12.59%-14.85%13.93%5.48% Cadre Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDRECadre3.7334 of 5 stars$29.17-0.5%$37.00+26.8%-12.6%$1.19B$567.56M35.142,240Upcoming EarningsPositive NewsNARIInari MedicalN/A$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.8542 of 5 stars$144.74-3.6%$218.90+51.2%-34.4%$4.31B$802.80M83.67760Upcoming EarningsBLCOBausch + Lomb3.8397 of 5 stars$12.05-0.1%$18.82+56.2%-20.4%$4.26B$4.79B-13.2412,500Earnings ReportNews CoverageGap DownSLNOSoleno Therapeutics4.6454 of 5 stars$68.93-1.5%$99.63+44.5%+67.6%$3.16BN/A-20.7630Upcoming EarningsPositive NewsIRTCiRhythm Technologies0.9812 of 5 stars$98.63-2.3%$119.73+21.4%-2.5%$3.10B$591.84M-27.101,790News CoveragePositive NewsTMDXTransMedics Group3.0328 of 5 stars$87.72-0.6%$122.70+39.9%-2.3%$2.97B$441.54M93.32210Upcoming EarningsAnalyst ForecastGap DownPRCTPROCEPT BioRobotics2.7276 of 5 stars$53.43+0.8%$91.43+71.1%+1.9%$2.93B$224.50M-27.40430Earnings ReportAnalyst RevisionPositive NewsHigh Trading VolumeNVSTEnvista4.4284 of 5 stars$14.88-2.0%$19.96+34.2%-18.3%$2.56B$2.51B-2.2912,700Analyst ForecastLMATLeMaitre Vascular2.1696 of 5 stars$84.72-1.8%$95.25+12.4%+40.0%$1.91B$219.86M46.30490News CoveragePositive NewsLIVNLivaNova3.8194 of 5 stars$34.61-2.7%$61.17+76.7%-33.6%$1.88B$1.25B82.402,900Upcoming EarningsPositive News Related Companies and Tools Related Companies NARI Alternatives INSP Alternatives BLCO Alternatives SLNO Alternatives IRTC Alternatives TMDX Alternatives PRCT Alternatives NVST Alternatives LMAT Alternatives LIVN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CDRE) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadre Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadre With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDRE Stock Free CDRE Stock Alerts